Immunosuppressed patients with immune-mediated inflammatory diseases benefit from high post-vaccination antibody levels against COVID-19
The Nor-vaC study underscores the importance of the role of repeated vaccination in patients in patients with immune-mediated inflammatory diseases on immunosuppressive therapies.